Based on their activity, SIRT1–SIRT5 agonists and SIRT6 and SIRT7 inhibitors may represent new therapeutic options for the treatment of psoriasis, but more studies are needed to confirm this eventuality. This evidence concerns the gene SIRT5 and psoriasis.